Titan Medical Inc.  

(Public, CVE:TMD)   Watch this stock  
Find more results for Bruce A. Wolffing
Sep 29 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.38 - 2.76
Open     -
Vol / Avg. 0.00/48,846.00
Mkt cap 249.34M
P/E     -
Div/yield     -
EPS -0.20
Shares 101.80M
Beta 0.05
Inst. own     -
Feb 10, 2015
Q4 2014 Titan Medical Inc Earnings Release

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -32.81% -202.08%
Return on average equity -46.79% -271.50%
Employees 12 -
CDP Score - -


Suite 1000, 170 University Avenue
+1-416-5487522 (Phone)

Website links


Titan Medical Inc. (Titan) is a development-stage company focused on the development and commercialization of robotic surgical technologies. The Company is developing the Amadeus Robotic Surgical Platform (Amadeus), a four-armed robotic surgical system. The development of Amadeus has three phases. The Amadeus system includes single and multiple port access capability with the objective of performing complex procedures directed by the surgeon team. During the year ended December 31, 2011, the Company announced its Amadeus Composer Surgical System, (Amadeus Composer), designed to allow for the expansion of robotic surgery into areas of surgical specialties and procedures. The Amadeus Composer is designed to allow surgeons to perform procedures within small to medium size surgical spaces such as ear, nose and throat applications.

Officers and directors

John T. Hargrove Chairman of the Board, Chief Executive Officer
Reiza Rayman M.D. President, Director
Age: 50
Stephen D. Randall Chief Financial Officer, Secretary
Dennis L Fowler Executive Vice President - Clinical and Regulatory Affairs
John Valvo Vice President
John E. Barker Independent Director
Martin C. Bernholtz Independent Director
Bruce Gilles Wolff M.D. Independent Director